Your browser doesn't support javascript.
loading
Machine Learning Combined with Radiomics Facilitating the Personal Treatment of Malignant Liver Tumors.
Sheng, Liuji; Yang, Chongtu; Chen, Yidi; Song, Bin.
Affiliation
  • Sheng L; Department of Radiology, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Yang C; Functional and Molecular Imaging Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Chen Y; Department of Radiology, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Song B; Functional and Molecular Imaging Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu 610041, China.
Biomedicines ; 12(1)2023 Dec 26.
Article in En | MEDLINE | ID: mdl-38255165
ABSTRACT
In the realm of managing malignant liver tumors, the convergence of radiomics and machine learning has redefined the landscape of medical practice. The field of radiomics employs advanced algorithms to extract thousands of quantitative features (including intensity, texture, and structure) from medical images. Machine learning, including its subset deep learning, aids in the comprehensive analysis and integration of these features from diverse image sources. This potent synergy enables the prediction of responses of malignant liver tumors to various treatments and outcomes. In this comprehensive review, we examine the evolution of the field of radiomics and its procedural framework. Furthermore, the applications of radiomics combined with machine learning in the context of personalized treatment for malignant liver tumors are outlined in aspects of surgical therapy and non-surgical treatments such as ablation, transarterial chemoembolization, radiotherapy, and systemic therapies. Finally, we discuss the current challenges in the amalgamation of radiomics and machine learning in the study of malignant liver tumors and explore future opportunities.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Biomedicines Year: 2023 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Biomedicines Year: 2023 Type: Article Affiliation country: China